Benefit/risk ratio of the antihistamines (H1-receptor antagonists) terfenadine and chlorpheniramine in children
- 30 June 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 124 (6), 979-983
- https://doi.org/10.1016/s0022-3476(05)83197-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- H1-Receptor AntagonistsDrug Safety, 1994
- AUDITORY EVENT‐RELATED POTENTIALS AND REACTION TIME IN CHILDREN EVALUATION OF COGNITIVE DEVELOPMENTDevelopmental Medicine and Child Neurology, 1993
- Structure-activity relationships within a series of analogues of the histamine H1-antagonist terfenadineEuropean Journal of Medicinal Chemistry, 1993
- Comparison of the effects of single doses of the new H1-receptor antagonists loratadine and terfenadine versus placebo in childrenThe Journal of Pediatrics, 1991
- Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderlyJournal of Allergy and Clinical Immunology, 1990
- Differential cognitive effects of terfenadine and chlorpheniramineJournal of Allergy and Clinical Immunology, 1989
- The pharmacokinetics and pharmacodynamics of terfenadine in childrenJournal of Allergy and Clinical Immunology, 1987
- Psychomotor Effects of Astemizole and Chlorpheniramine, Alone and in Combination with AlcoholInternational Clinical Psychopharmacology, 1987
- Multicenter, double-blind, placebo-controlled trial of terfenadine suspension in the treatment of fall-allergic rhinitis in childrenJournal of Allergy and Clinical Immunology, 1986
- Pharmacokinetics and efficacy of chlorpheniramine in childrenJournal of Allergy and Clinical Immunology, 1982